Prosecution Insights
Last updated: August 18, 2026

Examiner: ULSH, DUNG T

Tech Center 3700 • Art Units: 3763 3771 3783

This examiner grants 79% of resolved cases

Performance Statistics

78.6%
Allow Rate
+8.6% vs TC avg
400
Total Applications
+16.7%
Interview Lift
1079
Avg Prosecution Days
Based on 374 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
30.2%
§102 Novelty
39.6%
§103 Obviousness
23.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18038902 MEDICAL DEVICE INSUFFLATION ADAPTOR Final Rejection Intuitive Surgical Operations, Inc.
18280870 Drug Administration Management System and Operation Method Thereof Non-Final OA LG CHEM, LTD.
18142179 EXPANDABLE SHEATH FOR TRANSAXILLARY ACCESS Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18588048 DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE Non-Final OA Eli Lilly and Company
18509779 MEDICATION DELIVERY DEVICE WITH A SENSED ELEMENT Non-Final OA Eli Lilly and Company
17700152 Multi-Purpose Delivery Needle Non-Final OA Bard Access Systems, Inc.
18358705 CATHETER WITH PULL WIRE BAND ELECTRODE Final Rejection Medtronic, Inc.
18705024 Alarm Indicator for Drug Delivery Device Non-Final OA Becton, Dickinson and Company
18238980 CATHETER HAVING REINFORCEMENT FIBERS AND RELATED DEVICES AND METHODS Non-Final OA Becton, Dickinson and Company
18135808 Indicators for Instrument Advancement Device Final Rejection Becton, Dickinson and Company
18114352 Vascular Access Instrument Non-Final OA Becton, Dickinson and Company
18460316 Supplemental Device for Attachment to an Injection Device Non-Final OA SANOFI-AVENTIS DEUTSCHLAND GMBH
18559128 A COMPONENT AND A SUB-ASSEMBLY FOR A MEDICAMENT DELIVERY Non-Final OA SHL MEDICAL AG
17775650 MEDICAMENT DELIVERY DEVICE Final Rejection SHL MEDICAL AG
18270224 DRUG INFUSION DEVICE WITH SECURITY BASE Final Rejection MEDTRUM TECHNOLOGIES INC.
18270226 SKIN PATCH DRUG INFUSION DEVICE Final Rejection MEDTRUM TECHNOLOGIES INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month